SCHEMBL3514569

SCHEMBL3514569

COc1cc(CCC(=O)c2ccc(C(F)(F)F)cc2F)cc(OC)c1OC(C)(C)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 17/20 0.46
PPARD Q03181 15/20 0.46
PPARG P37231 14/20 0.46
FFAR1 O14842 1/20 0.40
FFAR2 O15552 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3510810 0.88 PPARD (0.52) PPARAPPARDPPARG
SCHEMBL3512325 0.84 PPARA (0.50) PPARAPPARDPPARGFFAR1FFAR2
SCHEMBL3514263 0.77 PPARD (0.52) PPARAPPARDPPARG
SCHEMBL3512023 0.77 PPARD (0.52) PPARAPPARDPPARG
SCHEMBL3512496 0.76 NPC1 (0.47) PPARAPPARDPPARG
SCHEMBL3510698 0.75 PPARD (0.48) PPARAPPARDPPARG
SCHEMBL3512049 0.74 PPARD (0.44) PPARAPPARDPPARG
SCHEMBL3511900 0.73 PPARA (0.46) PPARAPPARDPPARG
SCHEMBL3513490 0.72 PPARA (0.41) PPARAPPARDPPARGFFAR1
SCHEMBL1935010 0.72 PPARD (0.57) PPARAPPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101506139-B Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT 2012-10-10 CN disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
WO-2007147880-A1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof DPP3, DPP8, DPP4 PPARA 11/4885PPARD 9/4885PPARG 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.